These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. II. Various methodologic aspects of their analysis]. Faryna M Endokrynol Pol; 1986; 37(4):153-61. PubMed ID: 2881779 [No Abstract] [Full Text] [Related]
7. The implications of "thyroid-growth-immunoglobulins" (TGI) for the understanding of sporadic nontoxic nodular goitre. Doniach D; Chiovato L; Hanafusa T; Bottazzo GF Springer Semin Immunopathol; 1982; 5(4):433-46. PubMed ID: 6131546 [No Abstract] [Full Text] [Related]
8. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis]. Roos M; Sjöberg O; Axelsson O; Karlsson FA Lakartidningen; 2008 Jan 16-22; 105(3):120-4. PubMed ID: 18290505 [No Abstract] [Full Text] [Related]
9. Radioreceptor assay study of TSH receptor antibody in thyroid diseases. Chang TC; Chen FW; Chang CC; Liaw KY Taiwan Yi Xue Hui Za Zhi; 1985 Jan; 84(1):18-26. PubMed ID: 2860200 [No Abstract] [Full Text] [Related]
10. Clinical relevance of immunological markers in Graves' disease. Mann K; Saller B; Hörmann R Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726 [No Abstract] [Full Text] [Related]
11. Detection of thyroid-stimulating antibodies in sera of patients with Graves' disease--clinical and experimental studies. Chen G; Ye WX J Tongji Med Univ; 1987; 7(1):35-9. PubMed ID: 2885423 [No Abstract] [Full Text] [Related]
12. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983. Munro DS J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408 [No Abstract] [Full Text] [Related]
13. TSH receptor antibody in autoimmune thyroiditis and its clinical significance. Chang TC; Chen FW; Chang CC; Liaw KY Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):748-54. PubMed ID: 2878965 [No Abstract] [Full Text] [Related]
17. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy]. Heberling HJ; Bierwolf B; Kuhlmann E; Klugmann T; Dietel P; Fischer S Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115 [TBL] [Abstract][Full Text] [Related]
18. Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism. Chang TC; Chang CC; Chen FW; Liaw KY Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1177-82. PubMed ID: 2880926 [No Abstract] [Full Text] [Related]
19. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [TBL] [Abstract][Full Text] [Related]
20. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Kosugi S; Ban T; Akamizu T; Kohn LD Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]